pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,836 catalysts · 5,256 phase readout · 2,323 8k filing · 321 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 52 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: pdufa×type: phase readout×clear all
type
  • phase readout5,256
  • 8k filing2,323
  • pdufa321
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT06786832: Characterization, Treatment, and Long-term Follow-up of Fatigued Patients in Primary Care

Sponsor: Karolinska Institutet. Phase: NA. Conditions: Fatigue, Fatigue Post Viral, Exhaustion Disorder, Fatigue Symptom, Fatigue Related to Cancer Treatment

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07374198: Effect of Continuous Intraoperative Esketamine Infusion on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Mild-to-Severe Depression

Sponsor: Chinese PLA General Hospital. Phase: NA. Conditions: Depression, Anxiety, S-ketamine, Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07505563: MiniFlo for Advanced Dupuytren's Disease

Sponsor: Azienda Ospedaliera Universitaria Integrata Verona. Phase: NA. Conditions: Dupuytren's Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT07256093: The Effectiveness of Acceptance and Commitment Therapy (ACT) on Dysfunctional Attitudes and Difficulties in Emotion Regulation Among University Students in Malaysia

Sponsor: Universiti Sains Malaysia. Phase: NA. Conditions: Anxiety, Depression, Stress

full page →ctgov ↗
›COMPLETEDphase readoutNCT05803421: A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Type 2 Diabetes, Obesity, Overweight or Obesity, Overweight, Cardiovascular Diseases, Chronic Kidney Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07700121: PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma

Sponsor: Abramson Cancer Center at Penn Medicine. Phase: EARLY_PHASE1. Conditions: Unresectable or Metastatic Melanoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06327321: Vitiligo Treatment by Targeting TYK2 Mediated Responses

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE2. Conditions: Vitiligo, Generalized

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07415616: Cold vs Warm Enteral Feeding and Gastric Emptying in Adult ICU Patients

Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital. Phase: NA. Conditions: Gastric Emptying, Enteral Nutrition (Food for Special Medical Purposes)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07579416: Bruxism, Anxiety, and Periodontal Status Among Dental Students

Sponsor: Al-Hawash Private University. Phase: . Conditions: Bruxism, Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT07477704: A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE2. Conditions: Hypercholesterolemia

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07382804: Mobile Behavioral Activation Program With Wearable Sensors and Secure Activity Verification

Sponsor: Truway Health, Inc.. Phase: NA. Conditions: Health Behavior, Behavioral Activation, Sedentary Behavior

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07680504: A Pilot Superiority Study Comparing the Efficacy of a Combination of a Glenohumeral Intra-articular Injection With a Suprascapular Nerve Block Versus a Glenohumeral Intra-articular Corticosteroid Injection in Retractile Capsulitis

Sponsor: Nantes University Hospital. Phase: PHASE2. Conditions: Retractile Capsulitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05139004: 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome

Sponsor: City of Hope Medical Center. Phase: PHASE1. Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07383584: The Impact of Extending Sleep Before Joint-replacement Surgery on Post-surgical Pain

Sponsor: Defense and Veterans Center for Integrative Pain Management. Phase: NA. Conditions: Joint (Knee or Hip Replacement)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07698184: The Condition of the Temporomandibular Joint in Hemiplegia

Sponsor: Ayşe Ukbe Baykut. Phase: . Conditions: Hemiplegia, Temporomandibular Disorder (TMD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT00009633: Follow-up Visit of High Risk Infants

Sponsor: NICHD Neonatal Research Network. Phase: . Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07664033: AI-based Model for Rehabilitation Engagement and Motor Performance Evaluation in Pediatric Patients: A Pilot Study

Sponsor: IRCCS Eugenio Medea. Phase: NA. Conditions: Neuromotor Impairments

full page →ctgov ↗
›COMPLETEDphase readoutNCT03489733: Prevention of Allergic Diseases in Infants

Sponsor: HiPP GmbH & Co. Vertrieb KG. Phase: NA. Conditions: Atopic Diseases

full page →ctgov ↗
›SUSPENDEDphase readoutNCT05967533: The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors

Sponsor: University of California, Davis. Phase: PHASE1. Conditions: Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Melanoma, Advanced Renal Cell Carcinoma, Advanced Triple-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer (AJCC) v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Stage III Colorectal Cancer AJCC v8, Stage III Lung Cancer AJCC v8, Stage III Renal Cell Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8

full page →ctgov ↗
›COMPLETEDphase readoutNCT06508333: Efficacy and Safety of Vitamin D Supplementation Combined With Alarm Therapy in Treating Nocturnal Enuresis

Sponsor: Xing Liu. Phase: NA. Conditions: Enuresis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05863052: Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Sponsor: University of Oklahoma. Phase: . Conditions: Immune Checkpoint Inhibitors, Metastatic Solid Tumor, Nonsmall Cell Lung Cancer, Melanoma, Renal Cell Carcinoma, Gastrointestinal Cancer, Squamous Cell Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04529252: Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases

Sponsor: Mayo Clinic. Phase: . Conditions: Spinocerebellar Ataxias, Cerebellar Ataxia, Nucleotide Repeat Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT04544852: Uncovering and Overcoming the Barriers of Colorectal Cancer Screening Amongst Spouses of Patients With Colorectal Cancer

Sponsor: National University Health System, Singapore. Phase: NA. Conditions: Colorectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT03997552: NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration

Sponsor: Universidad de Murcia. Phase: NA. Conditions: Periodontitis, Periodontal Diseases, Periodontal Pocket

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07689188: Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa

Sponsor: Harrison Dermatology. Phase: PHASE2. Conditions: Hidradenitis Suppurativa (HS)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06408103: Efficacy of a Multicomponent Intervention on Cognitive Function for the Caregiver-patient Dyad

Sponsor: Universidad de Santander. Phase: NA. Conditions: Mild Cognitive Impairment

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07524803: Lung Cancer Screening for Early Detection of Suspicious Lung Nodules in Latin America(LUCAS-LATAM)

Sponsor: Latin American Consortium for the Lung Cancer Research. Phase: . Conditions: Lung Cancer Screening

full page →ctgov ↗
›RECRUITINGphase readoutNCT06280703: A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

Sponsor: Eli Lilly and Company. Phase: PHASE1. Conditions: Healthy, Type 1 Diabetes Mellitus

full page →ctgov ↗
›RECRUITINGphase readoutNCT07352527: New Clinical Decision Support Score Based on Steroid Hormone Profiling in the Diagnosis of MACS

Sponsor: University Hospital, Bordeaux. Phase: . Conditions: Endocrine Disease

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05870527: Pupillary Dilation During Post-Auricular Vagal Nerve Stimulation

Sponsor: NYU Langone Health. Phase: NA. Conditions: Hearing Loss

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06491927: Long Term Follow-up for RGX-202

Sponsor: REGENXBIO Inc.. Phase: . Conditions: Duchenne Muscular Dystrophy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07336017: Impact on Postpartum Anal Incontinence of an Educational Program for Delivery Room Staff

Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Anal Incontinence

full page →ctgov ↗
›RECRUITINGphase readoutNCT05883540: Lysergic Acid Diethylamide (LSD) in Palliative Care

Sponsor: University Hospital, Basel, Switzerland. Phase: PHASE2. Conditions: Palliative Care, Pain, Anxiety, Depression, Demoralization, Psychological Distress, Quality of Life, Caregiver Burden, Fear of Death, Existential Distress

full page →ctgov ↗
›COMPLETEDphase readoutNCT05265689: Study to Improve Adolescent Bicycling Safety

Sponsor: Cara J. Hamann. Phase: NA. Conditions: Bicycling, Knowledge, Adolescent, Self Efficacy, Education, Attitudes, Practice, Safety, Behavior

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07499089: Together-Breast Cancer Support Platform

Sponsor: Cedars-Sinai Medical Center. Phase: . Conditions: Breast Cancer, Breast Cancer Survivors

full page →ctgov ↗
›COMPLETEDphase readoutNCT07396350: IMMEDIATE IMPLANT With Different Types of Membrane

Sponsor: Mansoura University. Phase: NA. Conditions: Tooth Extraction

full page →ctgov ↗
›RECRUITINGphase readoutNCT07416591: Role of Saline Infusion Sonohysterography in Detection of Pelvic Adhesions in Infertile Women

Sponsor: Sohag University. Phase: NA. Conditions: Infertile Women With Pelvic Adhesions

full page →ctgov ↗
›RECRUITINGphase readoutNCT07031791: PETRA: Pictorial Assessment of Task Occurrence and Upper Limb Avoidance Behaviors

Sponsor: University Hospital, Angers. Phase: . Conditions: Thoraco-brachial Outlet Syndrome, ADAP-shoulder Scale, PETRA

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07325591: Efficacy and Safety of Tazbentetol in ALS Participants

Sponsor: Spinogenix. Phase: PHASE2. Conditions: Amyotrophic Lateral Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07556874: Descriptive Analysis of Surgeries in Patients With Multiple Osteochondromas

Sponsor: Istituto Ortopedico Rizzoli. Phase: . Conditions: Multiple Osteochondroma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07494318: Advanced GastroInstestinal(GI) Surgery Training in Residency and Fellowship.

Sponsor: Methodist Health System. Phase: . Conditions: Gastro-Intestinal Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT03108118: Diaphragm Injury and Dysfunction During Mechanical Ventilation

Sponsor: University Health Network, Toronto. Phase: . Conditions: Respiratory Insufficiency, Diaphragm Injury, Mechanical Ventilation Complication

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07334197: Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy

Sponsor: Tanta University. Phase: NA. Conditions: Ppm, Cardiomyopathy

full page →ctgov ↗
›COMPLETEDphase readoutNCT06567860: Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations

Sponsor: La Jolla Institute for Immunology. Phase: PHASE4. Conditions: Influenza A

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07396220: Psychotherapy Combined With Intranasal Esketamine for the Treatment of Suicidal Ideation

Sponsor: University of California, San Diego. Phase: NA. Conditions: Suicidal Ideation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06617182: Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.

Sponsor: Yongquan Shi. Phase: PHASE2. Conditions: Radiation Enteritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07484724: A Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma

Sponsor: Shanghai Junshi Bioscience Co., Ltd.. Phase: PHASE2. Conditions: Advanced Esophageal Squamous Cell Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06628323: Neuro-VR: Augmenting a Virtual Reality-based Therapy With Biofeedback for Auditory Hallucinations

Sponsor: University Hospital Bispebjerg and Frederiksberg. Phase: NA. Conditions: Auditory Hallucinations, Schizophrenia

full page →ctgov ↗
›COMPLETEDphase readoutNCT07598123: Effects of Multi-component Exercise on Physical Performance and Sleep Quality in Older Adults

Sponsor: Tunghai University. Phase: NA. Conditions: Aging, Sleep Quality, Physical Performance

full page →ctgov ↗
›TERMINATEDphase readoutNCT06692959: A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer

Sponsor: University of Southampton. Phase: PHASE2. Conditions: Colorectal Cancer

full page →ctgov ↗
← prev
page 98 of 117
next →